These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29463912)

  • 1. Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders.
    Domi E; Barbier E; Augier E; Augier G; Gehlert D; Barchiesi R; Thorsell A; Holm L; Heilig M
    Neuropsychopharmacology; 2018 Aug; 43(9):1805-1812. PubMed ID: 29463912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociating Motivational From Physiological Withdrawal in Alcohol Dependence: Role of Central Amygdala κ-Opioid Receptors.
    Kissler JL; Walker BM
    Neuropsychopharmacology; 2016 Jan; 41(2):560-7. PubMed ID: 26105136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety.
    Schank JR; Goldstein AL; Rowe KE; King CE; Marusich JA; Wiley JL; Carroll FI; Thorsell A; Heilig M
    Addict Biol; 2012 May; 17(3):634-47. PubMed ID: 22515275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled study of the kappa opioid receptor antagonist, CERC-501, in a human laboratory model of smoking behavior.
    Jones JD; Babalonis S; Marcus R; Vince B; Kelsh D; Lofwall MR; Fraser H; Paterson B; Martinez S; Martinez DM; Nunes EV; Walsh SL; Comer SD
    Addict Biol; 2020 Jul; 25(4):e12799. PubMed ID: 31240842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GABA
    Augier E; Dulman RS; Damadzic R; Pilling A; Hamilton JP; Heilig M
    Neuropsychopharmacology; 2017 Aug; 42(9):1789-1799. PubMed ID: 28294133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species differences in the effects of the κ-opioid receptor antagonist zyklophin.
    Sirohi S; Aldrich JV; Walker BM
    Alcohol; 2016 Mar; 51():43-9. PubMed ID: 26992699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nociceptin/orphanin FQ receptor agonist SR-8993 as a candidate therapeutic for alcohol use disorders: validation in rat models.
    Aziz AM; Brothers S; Sartor G; Holm L; Heilig M; Wahlestedt C; Thorsell A
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3553-63. PubMed ID: 27515665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic κ-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats.
    Walker BM; Zorrilla EP; Koob GF
    Addict Biol; 2011 Jan; 16(1):116-9. PubMed ID: 20579007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of orally-bioavailable short-acting kappa opioid receptor-selective antagonist LY2456302 on nicotine withdrawal in mice.
    Jackson KJ; Jackson A; Carroll FI; Damaj MI
    Neuropharmacology; 2015 Oct; 97():270-4. PubMed ID: 26044637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders.
    Rorick-Kehn LM; Witkin JM; Statnick MA; Eberle EL; McKinzie JH; Kahl SD; Forster BM; Wong CJ; Li X; Crile RS; Shaw DB; Sahr AE; Adams BL; Quimby SJ; Diaz N; Jimenez A; Pedregal C; Mitch CH; Knopp KL; Anderson WH; Cramer JW; McKinzie DL
    Neuropharmacology; 2014 Feb; 77():131-44. PubMed ID: 24071566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of DA-Phen, a dopamine-aminoacidic conjugate, on alcohol intake and forced abstinence.
    Sutera FM; De Caro V; Cannizzaro C; Giannola LI; Lavanco G; Plescia F
    Behav Brain Res; 2016 Sep; 310():109-18. PubMed ID: 27155501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The one-two punch of alcoholism: role of central amygdala dynorphins/kappa-opioid receptors.
    Kissler JL; Sirohi S; Reis DJ; Jansen HT; Quock RM; Smith DG; Walker BM
    Biol Psychiatry; 2014 May; 75(10):774-82. PubMed ID: 23611261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.
    Walker BM; Koob GF
    Neuropsychopharmacology; 2008 Feb; 33(3):643-52. PubMed ID: 17473837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurokinin-1 receptor antagonism attenuates neuronal activity triggered by stress-induced reinstatement of alcohol seeking.
    Schank JR; Nelson BS; Damadzic R; Tapocik JD; Yao M; King CE; Rowe KE; Cheng K; Rice KC; Heilig M
    Neuropharmacology; 2015 Dec; 99():106-14. PubMed ID: 26188146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Effects of the novel relatively short-acting kappa opioid receptor antagonist LY2444296 in behaviors observed after chronic extended-access cocaine self-administration in rats".
    Valenza M; Butelman ER; Kreek MJ
    Psychopharmacology (Berl); 2017 Aug; 234(15):2219-2231. PubMed ID: 28550455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kappa-opioid receptors and relapse-like drinking in long-term ethanol-experienced rats.
    Hölter SM; Henniger MS; Lipkowski AW; Spanagel R
    Psychopharmacology (Berl); 2000 Dec; 153(1):93-102. PubMed ID: 11255932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel, selective, brain-penetrant neuropeptide Y Y2 receptor antagonist, JNJ-31020028, tested in animal models of alcohol consumption, relapse, and anxiety.
    Cippitelli A; Rezvani AH; Robinson JE; Eisenberg L; Levin ED; Bonaventure P; Motley ST; Lovenberg TW; Heilig M; Thorsell A
    Alcohol; 2011 Sep; 45(6):567-76. PubMed ID: 21145691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Novel μ-Opioid Receptor Antagonist GSK1521498 Decreases Both Alcohol Seeking and Drinking: Evidence from a New Preclinical Model of Alcohol Seeking.
    Giuliano C; Goodlett CR; Economidou D; García-Pardo MP; Belin D; Robbins TW; Bullmore ET; Everitt BJ
    Neuropsychopharmacology; 2015 Dec; 40(13):2981-92. PubMed ID: 26044906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats.
    Ciccocioppo R; Martin-Fardon R; Weiss F
    Neuropsychopharmacology; 2002 Sep; 27(3):391-9. PubMed ID: 12225696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective κ-opioid receptor antagonist JDTic attenuates the alcohol deprivation effect in rats.
    Uhari-Väänänen J; Eteläinen T; Bäckström P; Oinio V; Carroll FI; Raasmaja A; Kiianmaa K; Piepponen P
    Eur Neuropsychopharmacol; 2019 Dec; 29(12):1386-1396. PubMed ID: 31679889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.